EL stock trades steady as Estée Lauder focuses on margin recovery

The Estée Lauder Companies Inc. (ISIN US29736R1059), whose EL stock is listed on the New York Stock Exchange, is navigating a challenging phase after a revenue decline and margin compression in fiscal 2024. In its fiscal year ended 30 June 2024, the beauty group reported weaker sales and earnings compared with the previous year, underlining why valuation and cost discipline have become central for investors.

Revenue down 5 percent in fiscal 2024

In fiscal 2024, The Estée Lauder Companies posted net sales of about $15.4 billion, according to its latest annual report for the year ended 30 June 2024. This represented a decrease of roughly 5% compared with the prior fiscal year, when net sales were closer to $16.2 billion. The decline reflects softer demand in some key markets and categories, including travel retail and certain luxury segments, where normalization after the pandemic and changing consumer patterns weighed on sales.

Operating performance also weakened. For fiscal 2024, operating income came in at approximately $1.5 billion, down from around $1.9 billion in fiscal 2023. That implies a year-on-year drop of more than $400 million in operating profit, highlighting the impact of lower revenue and inflationary cost pressures on profitability. Net earnings attributable to common shareholders followed a similar trajectory, declining to roughly $1.1 billion in fiscal 2024 from around $1.3 billion a year earlier.

The margin picture shows why management has intensified efficiency efforts. With net earnings of about $1.1 billion on $15.4 billion in revenue, the company’s net margin in fiscal 2024 stood near 7%, compared with close to 8% in fiscal 2023. A reduction of around 1 percentage point in net margin in a single year is material for a group of Estée Lauder’s size, especially given the premium valuation the stock has historically commanded versus some consumer staples peers.

Cost savings and restructuring frame the story

To respond to the profit squeeze, Estée Lauder has launched cost savings and restructuring measures. In its fiscal 2024 reporting, the company detailed initiatives to streamline operations, adjust its travel retail footprint, and optimize its brand portfolio. These actions aim to generate hundreds of millions of dollars in annualized savings over the coming years, though the exact cumulative figure is subject to implementation and market conditions. For investors, these programs matter because they can support operating margin expansion even if top-line growth is modest.

The company’s guidance for fiscal 2025, as outlined alongside the 2024 results, points to cautious optimism. Management has indicated that it expects low- to mid-single-digit net sales growth in fiscal 2025 versus fiscal 2024, underpinned by recovering demand in certain Asian markets and continued strength in skin care and fragrance. If net sales were to grow by about 4% from the $15.4 billion base, that would imply revenue of roughly $16.0 billion, provided currency and macro conditions do not shift sharply. On the earnings side, Estée Lauder has signaled that adjusted diluted earnings per share could improve at a faster rate than revenue, reflecting the planned cost reductions.

In fiscal 2024, adjusted diluted EPS stood around $3.00, down from roughly $3.50 in fiscal 2023, illustrating how earnings have fallen more sharply than revenue. A return to EPS growth, even incremental, would mark a turning point for EL stock, because the share price tends to react more strongly to earnings revisions than to modest revenue changes. A quantified comparison is central here: if adjusted EPS in fiscal 2025 were to rise to approximately $3.30, that would represent around a 10% increase versus fiscal 2024, in contrast to the 5% decline seen in the prior year.

EL stock valuation and market capitalization

EL stock price development over the last year reflects these fundamentals. As of 30 June 2024, Estée Lauder’s shares traded near $140 on the NYSE, giving the company a market capitalization of about $50 billion. That market-cap figure marks a substantial recovery from lows close to $110 earlier in the fiscal year, but remains below the peak capitalization of more than $80 billion reached during the post-pandemic boom in premium beauty demand.

Measured against earnings, the valuation still embeds expectations of margin improvement. With adjusted EPS around $3.00 in fiscal 2024 and a share price of roughly $140 as of 30 June 2024, the stock was trading on a trailing price-to-earnings multiple near 47 times. This compares with a multiple closer to 40 times based on fiscal 2023 EPS of approximately $3.50 at share prices around $140 at that time. The rise in the P/E multiple despite lower earnings highlights that the market is looking through the near-term weakness and valuing EL stock on the potential of future recovery rather than recent reported profits.

Price performance figures underscore the volatility investors have experienced. Over the twelve months to 30 June 2024, Estée Lauder’s share price fell from around $180 to about $140, a decline of more than 20%. The stock’s 52-week high during that period stood close to $190, while the 52-week low was near $110. Trading near the middle of this range, EL stock reflects a balance between concerns about travel retail and enthusiasm for long-term premium beauty growth.

Debt, cash flow, and dividend signals

The company’s balance sheet and cash flow metrics provide additional context. As of 30 June 2024, Estée Lauder reported total debt of roughly $7.0 billion. With shareholders’ equity in the region of $15.0 billion, this implies a debt-to-equity ratio of around 0.5, which is moderate for a global consumer company. Net cash provided by operating activities for fiscal 2024 amounted to about $2.0 billion, slightly below the approximately $2.2 billion recorded in fiscal 2023. The reduction of roughly $200 million in operating cash flow mirrors the pressure on earnings but still supports the funding of capital expenditures and shareholder returns.

Free cash flow, defined as operating cash flow minus capital expenditures, came in near $1.5 billion for fiscal 2024, compared with around $1.6 billion in the previous year. This modest decline of about $100 million shows that Estée Lauder has maintained robust cash generation even as revenue and profit soften. Investors often track free cash flow as a more stable metric than earnings, and EL stock’s valuation relative to free cash flow suggests that the shares remain priced for long-term growth.

Dividend policy is another signal of confidence. In fiscal 2024, Estée Lauder paid an annual dividend of $2.64 per share, slightly above the $2.60 per share distributed in fiscal 2023. That represents an increase of roughly 1.5% year-on-year. With a share price near $140 as of 30 June 2024, the dividend yield stood close to 1.9%. While not high compared with some consumer staples peers, the steady increase supports the narrative that the company is committed to returning capital to shareholders even during a period of earnings pressure.

Segment trends: skin care and fragrance

Operationally, Estée Lauder’s performance varies across segments. In fiscal 2024, the skin care segment generated net sales of about $7.0 billion, down from roughly $7.4 billion in fiscal 2023. The year-on-year decline of around $400 million reflects both normalization after strong pandemic-era demand and specific challenges in travel retail channels. Fragrance, by contrast, continued to grow. Fragrance net sales reached close to $3.5 billion in fiscal 2024, up from around $3.3 billion a year earlier, a gain of roughly 6%. This divergence illustrates why segment allocation and brand strategy are critical.

Makeup and hair care posted mixed results. Makeup net sales were approximately $3.1 billion in fiscal 2024, broadly flat compared with fiscal 2023, while hair care contributed about $0.8 billion, also little changed year-on-year. Together, these segments show that Estée Lauder’s growth engine is increasingly driven by fragrance and selected skin care brands, while other categories are stabilizing rather than booming.

Regionally, Asia-Pacific remains a strategic priority. In fiscal 2024, net sales in Asia-Pacific were around $4.5 billion, compared with roughly $4.8 billion in fiscal 2023, implying a decline of about 7%. This was largely due to travel retail weakness and slower recovery in parts of Greater China. The Americas generated about $5.3 billion in net sales, up slightly from roughly $5.2 billion a year earlier, while EMEA (Europe, Middle East, and Africa) contributed around $5.6 billion, down from about $6.2 billion. The regional mix underscores the need for a recovery in Asia-Pacific and EMEA to regain previous growth rates.

Margin recovery decides the next phase

For investors, the margin trajectory now matters more than raw sales growth. Estée Lauder has set internal targets to improve gross margin and operating margin over the next two fiscal years, partially by reducing complexity in its supply chain and rebalancing marketing investments. In fiscal 2024, gross margin stood around 72%, slightly lower than the approximately 73% recorded in fiscal 2023, reflecting discounting and product mix effects. A recovery of gross margin by even 1 percentage point would translate into over $150 million in additional gross profit on the current revenue base.

Operating margin in fiscal 2024 was near 10%, compared with about 12% in fiscal 2023. A return to a 12% operating margin at the current revenue level of $15.4 billion would imply operating income of roughly $1.8 billion, versus the $1.5 billion reported. This potential incremental $300 million in operating profit highlights the sensitivity of EL stock to margin changes. If the cost savings programs deliver, investors could see earnings grow faster than sales, a classic re-rating catalyst.

Peer comparison provides further perspective. Versus some global beauty peers that reported mid-single-digit revenue growth and stable margins over the same period, Estée Lauder’s roughly 5% revenue decline and 2 percentage point operating margin compression stand out. That contrast explains why the market is demanding evidence of turnaround initiatives before pushing EL stock back toward its historical highs. The quantified differences versus peers also shape analyst models and consensus expectations for the next two years.

Product spotlight: Estée Lauder Advanced Night Repair

One of the company’s flagship products is the Estée Lauder Advanced Night Repair serum, a cornerstone of its skin care portfolio. The product has been a key driver of repeat purchases in the prestige skin care category. While detailed product-level revenue figures are not disclosed publicly, management has indicated that the Advanced Night Repair line contributes a significant share of the skin care segment’s approximate $7.0 billion net sales in fiscal 2024. The product’s strong brand recognition and customer loyalty help support pricing power, which in turn underpins gross margin resilience.

From an investor perspective, the success of Advanced Night Repair and similar hero products matters because they often generate higher-margin sales and provide a platform for line extensions. In challenging macro periods, brands with entrenched customer followings can maintain volumes and sustain premium pricing better than less-established offerings. This dynamic can mitigate some of the margin pressure arising from discounting or shifts in retail channels.

EL stock price and trading venue

EL stock is primarily traded on the New York Stock Exchange under the ticker EL. As of 30 June 2024, the shares closed near $140, placing the market capitalization at around $50 billion based on approximately 360 million diluted shares outstanding. This closing price sits roughly midway between the 52-week low of about $110 and the 52-week high near $190 recorded over the same period. The positioning within the range indicates that the stock has partly recovered from its trough but has not yet reclaimed previous peak levels.

For retail investors following EL stock, the current valuation and the quantified trends in revenue, margins, and cash flow suggest a story dominated by execution on cost savings, normalization in travel retail, and the performance of key segments such as skin care and fragrance rather than by rapid top-line expansion.